Novo Nordisk: Priced Like Best Days Are Over [Upgrade]

Core Viewpoint - Novo Nordisk's stock has decreased by over 50% since last July, making it an attractive investment opportunity due to its low valuation and strong fundamentals, including an 18% increase in key financial metrics [1]. Group 1: Stock Performance - The stock of Novo Nordisk has dropped more than 50% since July of the previous year [1]. Group 2: Financial Fundamentals - The company has demonstrated impressive fundamentals, highlighted by an 18% increase in key financial metrics [1].